White label ELPA - ClinicalTrials.eu

Study of Belzutifan and Palbociclib for Patients with Advanced Renal Cell Carcinoma

Not recruiting

1 1 1 1
Investigated diseases:
- Renal cell carcinoma
Investigated drugs:
- Belzutifan
- Palbociclib
Effects of Diclofenac Diethylamine Gel on Physical Activity and Quality of Life in Patients with Mild Knee Osteoarthritis

Not recruiting

3 1 1 1
Investigated diseases:
- Osteoarthritis
Investigated drugs:
- Diclofenac Diethylamine
Study on Mepolizumab for Children and Teens with Hypereosinophilic Syndrome

Not recruiting

3 1 1 1
Investigated diseases:
- Hypereosinophilic syndrome
Investigated drugs:
- Mepolizumab
Study of Venetoclax and Low Dose Cytarabine for Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Not recruiting

3 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
- Cytarabine
- Venetoclax
Long-Term Safety Study of Troriluzole for Patients with Obsessive Compulsive Disorder Not Responding to SSRI, Clomipramine, Venlafaxine, or Desvenlafaxine

Not recruiting

3 1 1
Investigated diseases:
- Anxiety disorder
Investigated drugs:
- Troriluzole
Long-Term Study of Ustekinumab for Patients with Crohn’s Disease Who Previously Lost Response to Treatment

Not recruiting

3 1 1 1
Investigated diseases:
- Crohn’s disease
Investigated drugs:
- Ustekinumab
Study on the Safety of Doravirine and Islatravir for HIV Patients Who Previously Participated in Doravirine/Islatravir Trials

Not recruiting

3 1 1
Investigated diseases:
- HIV infection
Investigated drugs:
- Doravirine
- Islatravir
Study of Nusinersen for Patients with Spinal Muscular Atrophy Previously Treated with Onasemnogene Abeparvovec

Not recruiting

3 1 1 1
Investigated drugs:
- Nusinersen
Study on the Effectiveness and Safety of Cenobamate for Patients Aged 12 and Older with Primary Generalized Tonic-Clonic Seizures

Not recruiting

3 1
Investigated diseases:
- Generalised tonic-clonic seizure
Investigated drugs:
- Cenobamate
Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Not recruiting

3 1 1
Investigated diseases:
- Dermatitis atopic
Investigated drugs:
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies